Intracranial Atherosclerotic Disease (ICAD) or Intracranial Stenosis

Stony Brook is Your ICAD Expert
Stony Brook Medicine has particular expertise in the medical and interventional management of ICAD, which refers to the narrowing of an artery inside the brain that is caused by atherosclerosis (also known as "hardening of the arteries"). This can also lead to TIA or ischemic stroke. While ICAD is most often treated with aggressive medical therapy (blood thinners, blood pressure medications and cholesterol medications), it does sometimes required treatment with intracranial angioplasty and stenting.

Dr. David Fiorella was a National Co-Principal Investigator for the pivotal Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS), which defined the standard of care for the treatment of this disease.

Our multidisciplinary expert team offers both in person and telemedicine consultations for the treatment of all cerebrovascular disease processes. Contact us for a consultation:

Cerebrovascular Neurosurgery:  (631) 444-1213
Endovascular Neurosurgery: (631) 444-1213
Vascular Neurology (Stroke Neurology): (631) 444-2599